Science vs. Lobbying - how to escape regulatory capture ?

Wednesday, 23 Sep 2015 09:00

Language

EVIDENCE POLICIES: THE EU'S EVIDENCE ASSESSMENT SYSTEMS AND POSSIBLE IMPROVEMENTS

The existing system of evidence appraisal in the EU : how do expert bodies work? What is the data they use? What are the problems they face from a regulatory capture perspective and how to solve them ? What about research policy

Programme:

Moderator: Benedek Javor MEP (Greens/EFA), Vice-Chair of the ITCO Intergroup Introduction: Erik Millstone, Sussex University

Panel I: How can independence and transparency policies contribute to strengthening the reliability of public scientific opinions on regulated products? What are the obstacles ? Are such policies enough ?

  • The European Medicines Agency and the management of clinical trials data: presentation by Noël Wathion (Chief Policy Adviser, European Medicines Agency), followed by responses by Sile Lane (Director of Campaigns, Sense about Science - on behalf of the All Trials campaign), Brendan Barnes (Global Health and IP Director, European Federation of Pharmaceutical Industries and Associations) and Fergal O'Reagan (European Ombudsman office) - Q&A
  • The European Food Safety Authority's management of data, methods and expertise: presentation by Hubert Deluyker (Scientific Adviser, European Food Safety Authority), followed by responses by Martin Pigeon (Corporate Europe Observatory), Paul Leonard (Head of Corporate Innovation and Technology Policy, BASF) and Petri Sarvamaa MEP (EPP) - Q&A
  • The troubled origins of the EU's impact assessment policy - Katherine Smith (University of Edinburgh)
  • What is wrong with evidence based policy?: Andrea Saltelli, Centre for the Study of the Sciences and the Humanities (SVT) - University of Bergen, retired from the European Commission's Joint Research Centre
  • The importance of regulation-induced innovation for sustainable development - Nicholas Ashford (Professor of Technology and Policy - Director, MIT Technology and Law Program)
  • The European Commission's new Scientific Advice Mechanism (SAM): Johannes Klumpers, European Commission, Head of Unit in DG RTD, responsible for the SAM taskforce
  • Q&A

Panel II: Policy impact assessments and the European Commission's new Independent Scientific Advice Mechanism: “Better regulation”, or better control of the regulators?

  • The troubled origins of the EU's impact assessment policy - Katherine Smith (University of Edinburgh)
  • What is wrong with evidence based policy?: Andrea Saltelli, Centre for the Study of the Sciences and the Humanities (SVT) - University of Bergen, retired from the European Commission's Joint Research Centre
  • The importance of regulation-induced innovation for sustainable development - Nicholas Ashford (Professor of Technology and Policy - Director, MIT Technology and Law Program)
  • The European Commission's new Scientific Advice Mechanism (SAM): Johannes Klumpers, European Commission, Head of Unit in DG RTD, responsible for the SAM taskforce
  • Q&A

Panel III: Investing in politically relevant knowledge production?

  • “Public Research should benefit Society” – statement by Aude Lapprand (Director, Fondation Sciences Citoyennes – confirmed) followed by a debate with the audience

Wrap-up: Erik Millstone, Sussex University Conclusive statements and next steps, Martin Pigeon (CEO) and MEP Benedek Javor

The Greens/European Free Alliance